Australia's healthtech sector is exhibiting structural, not cyclical, growth in 2026. The digital health market, valued at USD $8.9 Billion in 2025, is forecast to reach USD $31.1 Billion by 2034 at a CAGR of 14.92%, underpinned by AI-led diagnostics, remote patient monitoring, aged care digitisation and a Federal Government committing billions to national digital health infrastructure.

Alcidion Group (ASX: ALC) signed an Asset Sale Agreement on 16th May 2026 to acquire three Kyra patient flow products from Telstra Health: Kyra Patient Flow Manager, Kyra Queue Manager, and Kyra IQ. The upfront cash consideration is $3.0 Million, funded from Alcidion's existing cash reserves of $15.1 Million (no debt as of 31st March 2026), with a further earn-out of up to $1.0 Million tied to recurring revenue thresholds over 12 months post-completion. Completion is expected